Clinical Trials | May 08, 2026
Moderna’s mRNA flu vaccine outperforms standard shot in Phase 3 trial
NEJM study shows strong protection across strains
NEJM study shows strong protection across strains
Hair care & quick commerce shine
Approval strengthens the company’s growing international anti-infective portfolio
Pharma major reports FY26 revenue of Rs 9,204 crore with 16.6% growth
The Minister emphasised that scientific institutions must actively communicate their achievements and engage with stakeholders
The private funding rose 38% amid growing international collaborations and CDMO demand
Approval marks the second generic semaglutide clearance in Canada and strengthens OneSource’s position in complex injectable CDMO programs
Report highlights growing confidence in digitalisation and AI, even as healthcare leaders remain concerned about workforce gaps, cybersecurity, and data readiness
Pharma and healthcare stocks stay in focus as investors track earnings, USFDA approvals, hospital growth, and global market pressures
Growth was supported by stronger COVID vaccine sales and expanded government supply agreements in international markets
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
